Unveiling the Pharmacological Mechanisms of Eleutheroside E Against Postmenopausal Osteoporosis Through UPLC-Q/TOF-MS-Based Metabolomics

Postmenopausal osteoporosis (PMOP) is a common metabolic bone disease in postmenopausal women in the Worldwide, and seriously affects the quality of life of middle-aged and elderly women. Therefore, there is an urgent need to discover a highly effective drug for PMOP treatment. In this study, ultra-...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yong-Sheng, Hou, Zhan-Jiang, Li, You, Zheng, Beng-Beng, Wang, Jia-Ming, Wang, Wen-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479840/
https://www.ncbi.nlm.nih.gov/pubmed/32982736
http://dx.doi.org/10.3389/fphar.2020.01316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479840/
https://www.ncbi.nlm.nih.gov/pubmed/32982736
http://dx.doi.org/10.3389/fphar.2020.01316

Ejemplares similares